Jason V Coloma
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $6.2M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 2SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 2,59315,558 held (−14%) | $27.02 | $70K | +0.3% |
| Oct 2SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 31,908191,447 held (−14%) | $27.02 | $862K | +0.3% |
| Sep 4SEC | MAZEMaze Therapeutics, Inc. | Sell | 9,85240,148 held (−20%) | $26.38 | $260K | +2.8% |
| Sep 4SEC | MAZEMaze Therapeutics, Inc. | Sell | 1,37538,773 held (−3%) | $27.12 | $37K | -0.0% |
| Sep 4SEC | MAZEMaze Therapeutics, Inc. | Sell | 11,28227,491 held (−29%) | $26.01 | $293K | +4.2% |
| Sep 4SEC | MAZEMaze Therapeutics, Inc. | Sell | 12927,362 held (−0%) | $25.77 | $3K | +5.2% |
| Sep 3SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 2,59318,151 held (−12%) | $26.31 | $68K | +3.0% |
| Sep 3SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 31,908223,355 held (−13%) | $26.29 | $839K | +3.1% |
| Aug 5SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 2,43920,898 held (−10%) | $26.71 | $65K | +1.5% |
| Aug 5SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 15420,744 held (−1%) | $27.09 | $4K | +0.1% |
| Aug 5SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 30,304256,867 held (−11%) | $26.71 | $809K | +1.5% |
| Aug 5SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 1,604255,263 held (−1%) | $27.09 | $43K | +0.1% |
| Jul 2SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 2,59323,337 held (−10%) | $29.98 | $78K | -9.6% |
| Jul 2SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 30,311288,768 held (−9%) | $29.95 | $908K | -9.5% |
| Jul 2SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 1,597287,171 held (−1%) | $30.44 | $49K | -10.9% |
| Jun 24SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 1,953342,944 held (−1%) | $26.00 | $51K | +4.3% |
| Jun 24SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 2,04025,930 held (−7%) | $26.00 | $53K | +4.3% |
| Jun 24SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 23,865319,079 held (−7%) | $26.05 | $622K | +4.1% |
| Jun 3SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 6,090344,897 held (−2%) | $26.20 | $160K | +3.5% |
| Jun 3SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 55327,970 held (−2%) | $26.24 | $15K | +3.3% |
| May 27SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 4,504376,569 held (−1%) | $26.00 | $117K | +4.3% |
| May 27SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 2,47828,523 held (−8%) | $26.00 | $64K | +4.3% |
| May 27SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 25,582350,987 held (−7%) | $26.02 | $666K | +4.2% |
| May 18SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 1,822381,073 held (−0%) | $26.00 | $47K | +4.3% |
| May 18SEC | MAZEMaze Therapeutics, Inc. | Sell Plan | 11631,001 held (−0%) | $26.00 | $3K | +4.3% |
- Sell
CEO Jason V Coloma sold $70K of MAZE at $27.02 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Jason V Coloma sold $862K of MAZE at $27.02 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Jason V Coloma sold $293K of MAZE at $26.01 — cuts the stake by 29%.
- Sell
CEO Jason V Coloma sold $68K of MAZE at $26.31 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Jason V Coloma sold $839K of MAZE at $26.29 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Jason V Coloma sold $65K of MAZE at $26.71 — pre-scheduled 10b5-1 plan sale.